LISA-101 is a fluorogenic substrate for γ-Glutamyl Cyclotransferase (GGCT), which is upregulated in a wide range of cancers, including breast cancer.
M. Orlowski, P.G. Richman, and A. Meister, Biochemistry, 8, 1048 (1969). (Isolation and Identification of GGCT)
A.J. Oakley, T. Yamada, D. Liu, M. Coggan, A.G. Clark, and P.G. Board, J. Biol. Chem., 283, 22031 (2008). (Isolation and Identification of GGCT)
P. Gromov, I. Gromova, E. Friis, V. Timmermans-Wielenga, F. Rank, R. Simon, G. Sauter, and J.M.A. Moreira, J. Proteome Res., 9, 3941 (2010). (Proteomic Profiling of Mammary Carcinomas)
K. Takemura, H. Kawachi, Y. Eishi, K. Kitagaki, M. Negi, M. Kobayashi, K. Uchida, J. Inoue, J. Inazawa, T. Kawano, and P.G. Board, Human Pathol., 45, 331 (2014). (GGCT as a Diagnostic Marker in Esophageal Tumors)
R. Ran, Y. Liu, H. Gao, Q. Kuang, Q. Zhang, J. Tang, H. Fu, Z. Zhang, and Q. He, J. Pham. Sci., 104, 476 (2015). (siRNA for Treatment of Drug-Resistant Breast Cancer)
T. Yoshiya, H. Ii, S. Tsuda, S. Kageyama, T. Yoshiki and Y. Nishiuchi, Org. Biomol. Chem., doi: 10.1039/C5OB00086F (2015). (Development of LISA-101)
本公司网站所展示销售的产品仅供科研！
沪公网安备 31011202007337号
